Rady Children's Institute for Genomic Medicine
Stacey Seeloff is an experienced professional in strategic alliances and marketing within the biotechnology and diagnostics sectors. Currently serving as the Director of Strategic Alliances at Rady Children's Institute for Genomic Medicine, Stacey previously held leadership roles at Thermo Fisher Scientific, including Head of Strategic Alliance Support and Associate Director of Alliance Management, where responsibilities included managing global partnerships and supporting genetic sciences initiatives. Earlier experience includes senior marketing positions at Illumina and Novartis Vaccines & Diagnostics, where Stacey led product development and strategic marketing efforts. Additional roles at Ortho Clinical Diagnostics and the VA Medical Center established a foundation in medical technology and diagnostics. Stacey earned an Executive MBA from Pepperdine Graziadio Business School and a BS in Clinical Laboratory Sciences from Arizona State University.
Rady Children's Institute for Genomic Medicine
The Rady Children's Institute for Genomic Medicine is leading the way in advancing precision healthcare for infants and children through genomic and systems medicine research. Discoveries at the Institute are enabling rapid diagnosis and targeted treatment of critically ill newborns and pediatric patients at Rady Children’s Hospital-San Diego. The vision is to expand delivery of this integrated translational research process to enable the practice of precision pediatric medicine at children’s hospitals across California, the nation and the world. RCIGM is a subsidiary of Rady Children’s Hospital and Health Center. Learn more at www.RadyGenomics.org.